Digital Pathology Market cover

Digital Pathology Market by Applications (Academic Research, Drug Discovery & Development, and Disease Diagnosis [Cancer Cell Detection and Others]), Products (Software, Storage System, and Device [Slide Management System and Scanners]), End-users (Diagnostic Labs, Biotech & Pharma Companies, Hospitals, and Academic & Research Institutes), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2766
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 193
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global digital pathology market size is anticipated to register a considerable CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the increased emphasis on enhancing workflow efficiency as well as the demand for better diagnostic tools for chronic disease conditions.


Digital Pathology Market summary

Digital pathology is a subspecialty of pathology that focuses on data management using data acquired from digitized specimen slides. With the use of computer-based technologies, digital pathology performs virtual microscopy. Despite the fact that the basic viewing capabilities have remained relatively unchanged, digital pathology has resulted in considerable advances in pathology lab efficiency, workflow, and revenue. The user can transform glass slides into digital slides that can be managed, shared, examined, and analyzed on a computer monitor using digital pathology. The interpretation and quantification of biomarker expression within tissue slices can also be aided by automated image analysis methods. Digital pathology is used in healthcare for intraoperative diagnosis, diagnostic consultation, primary diagnosis, medical student & resident teaching, diagnostic decision support, peer review, manual and semi-quantitative immunohistochemistry (IHC) review, clinical research, and tumor boards.

The COVID-19 pandemic outbreak had negative impact on the market. During the pandemic, the number of pathological tests performed has declined significantly. Furthermore, lockdown and social distancing norms implemented by government agencies and companies has negatively affected the demand for these solutions. However, due to a considerable reduction of COVID instances worldwide, the market is projected to resume an uptrend operation eventually.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing adoption of digital pathology to enhance lab efficiency is expected to boost the market growth in the coming years.
  • Rising prevalence of chronic disease conditions is one of the key factors driving the market growth.
  • Lack of trained pathologists present a major challenge. This is anticipated to hamper the market growth in the projected period.
  • High cost associated with digital pathology systems are projected to hinder the market expansion during the forecast period.
  • Introduction of affordable scanners for private pathology practices is projected to create significant growth opportunities for the market in the near future.

Scope of the Report

The report on the global digital pathology market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Digital Pathology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Applications (Academic Research, Drug Discovery & Development, and Disease Diagnosis [Cancer Cell Detection and Others]), Products (Software, Storage System, and Device [Slide Management System and Scanners]), and End-users (Diagnostic Labs, Biotech & Pharma Companies, Hospitals, and Academic & Research Institutes)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Huron Technologies International, Inc.; F. Hoffmann-La Roche AG; ContextVision AB; Leica Biosystems (Danaher); Hamamatsu Photonics, Inc.; Olympus Corp.; MikroScan Technologies, Inc.; Inspirata, Inc.; 3DHISTECH Ltd.; Visiopharm A/S; and Koninklijke Philips N.V.

Market Segment Insights

Academic research segment to grow at a rapid pace

Based on applications, the global digital pathology market is segregated into academic research, drug discovery & development, and disease diagnosis. The disease diagnosis segment is further bifurcated into cancer cell detection and others. The academic research segment is expected to grow at a rapid pace during the forecast period owing to the increased adoption of digital pathology in several research studies, such as tumor morphological research. However, the disease diagnosis segment is anticipated to hold a key share of the market in the coming years due to the rising prevalence of chronic diseases globally.

Device segment to expand at a considerable CAGR

In terms of products, the market is segmented into software, storage system, and device. The device segment consists of slide management system and scanners. The device segment is projected to expand at a considerable CAGR during the forecast period attributed to enhanced resolution and increasing adoption for academic research activities. Additionally, high bandwidth connectivity and intuitive user interfaces is further expected to drive the segment growth.


Digital Pathology Market product

Hospitals segment to hold significant market share

On the basis of components, the global digital pathology market is divided into diagnostic labs, biotech & pharma companies, hospitals, and academic & research institutes. The hospitals segment is anticipated to hold significant market share in the coming years owing to wide adoption of digital scanning techniques in hospitals for better patient compliance and faster diagnosis. On the other hand, biotech & pharma companies segment is expected to grow significantly during the forecast period due to a rise in the usage of digital pathology in oncology clinical trials, drug development, and preclinical GLP pathology.

North America to constitute a key market share

In terms of regions, the global digital pathology market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the projected period attributed to the increased use of digital pathology for disease diagnosis as well as more favorable government initiatives across the region. However, the market of Asia Pacific is anticipated to expand at a rapid pace during the forecast period owing to the growing penetration of digital imaging in the region.


Digital Pathology Market region

Segments

Segments Covered in the Report

The global digital pathology market has been segmented on the basis of

Applications

  • Academic Research
  • Drug Discovery & Development
  • Disease Diagnosis
    • Cancer Cell Detection
    • Others

Products

  • Software
  • Storage System
  • Device
    • Slide Management System
    • Scanners

End-users

  • Diagnostic Labs
  • Biotech & Pharma Companies
  • Hospitals
  • Academic & Research Institutes

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Huron Technologies International, Inc.
  • F. Hoffmann-La Roche AG
  • ContextVision AB
  • Leica Biosystems (Danaher)
  • Hamamatsu Photonics, Inc.
  • Olympus Corp.
  • MikroScan Technologies, Inc.
  • Inspirata, Inc.
  • 3DHISTECH Ltd.
  • Visiopharm A/S
  • Koninklijke Philips N.V.

Competitive Landscape

Key players competing in the global digital pathology market are Huron Technologies International, Inc.; F. Hoffmann-La Roche AG; ContextVision AB; Leica Biosystems (Danaher); Hamamatsu Photonics, Inc.; Olympus Corp.; MikroScan Technologies, Inc.; Inspirata, Inc.; 3DHISTECH Ltd.; Visiopharm A/S; and Koninklijke Philips N.V. As part of their efforts to expand their client base and acquire a competitive advantage over competitors, manufacturers operating in the market have adopted various strategic initiatives, such as partnerships, collaborations, and mergers & acquisitions. Moreover, companies are focusing on investment in R&D for development and launching of new products to maintain their competitive positions in the market.

Digital Pathology Market keyplayers

For instance, in April 2021, Leica Biosystems and Paige collaborated to integrate Leica's digital pathology platform with Paige's AI-enabled research oncology software. This would give selected countries in North America and Europe access to computational pathology products for translational and clinical research. In April 2021, Philips and Ibex Medical Analytics teamed up to merge their digital pathology solutions with the latter's AI-powered Galen platform, boosting their services.
 

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. digital pathology Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. digital pathology Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. digital pathology Market - Supply Chain
  4.5. Global digital pathology Market Forecast
     4.5.1. digital pathology Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. digital pathology Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. digital pathology Market Absolute $ Opportunity
5. Global digital pathology Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. digital pathology Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global digital pathology Demand Share Forecast, 2019-2026
6. North America digital pathology Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America digital pathology Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America digital pathology Demand Share Forecast, 2019-2026
7. Latin America digital pathology Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America digital pathology Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America digital pathology Demand Share Forecast, 2019-2026
8. Europe digital pathology Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe digital pathology Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe digital pathology Demand Share Forecast, 2019-2026
9. Asia Pacific digital pathology Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific digital pathology Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific digital pathology Demand Share Forecast, 2019-2026
10. Middle East & Africa digital pathology Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa digital pathology Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa digital pathology Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global digital pathology Market: Market Share Analysis
  11.2. digital pathology Distributors and Customers
  11.3. digital pathology Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Huron Technologies International, Inc.
     11.4.2. F. Hoffmann-La Roche AG
     11.4.3. ContextVision AB
     11.4.4. Leica Biosystems (Danaher)
     11.4.5. Hamamatsu Photonics, Inc.
     11.4.6. Olympus Corp.
     11.4.7. MikroScan Technologies, Inc.

Segments Covered in the Report

The global digital pathology market has been segmented on the basis of

Applications

  • Academic Research
  • Drug Discovery & Development
  • Disease Diagnosis
    • Cancer Cell Detection
    • Others

Products

  • Software
  • Storage System
  • Device
    • Slide Management System
    • Scanners

End-users

  • Diagnostic Labs
  • Biotech & Pharma Companies
  • Hospitals
  • Academic & Research Institutes

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Huron Technologies International, Inc.
  • F. Hoffmann-La Roche AG
  • ContextVision AB
  • Leica Biosystems (Danaher)
  • Hamamatsu Photonics, Inc.
  • Olympus Corp.
  • MikroScan Technologies, Inc.
  • Inspirata, Inc.
  • 3DHISTECH Ltd.
  • Visiopharm A/S
  • Koninklijke Philips N.V.

Key players competing in the global digital pathology market are Huron Technologies International, Inc.; F. Hoffmann-La Roche AG; ContextVision AB; Leica Biosystems (Danaher); Hamamatsu Photonics, Inc.; Olympus Corp.; MikroScan Technologies, Inc.; Inspirata, Inc.; 3DHISTECH Ltd.; Visiopharm A/S; and Koninklijke Philips N.V. As part of their efforts to expand their client base and acquire a competitive advantage over competitors, manufacturers operating in the market have adopted various strategic initiatives, such as partnerships, collaborations, and mergers & acquisitions. Moreover, companies are focusing on investment in R&D for development and launching of new products to maintain their competitive positions in the market.

Digital Pathology Market keyplayers

For instance, in April 2021, Leica Biosystems and Paige collaborated to integrate Leica's digital pathology platform with Paige's AI-enabled research oncology software. This would give selected countries in North America and Europe access to computational pathology products for translational and clinical research. In April 2021, Philips and Ibex Medical Analytics teamed up to merge their digital pathology solutions with the latter's AI-powered Galen platform, boosting their services.
 

Buy Report